PHARMING GROUP NV - ADR (PHAR) Stock Cash Flow
NASDAQ:PHAR - Nasdaq - US71716E1055 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -3.68M | -8.51M | -12.01M | 14.99M | 23.08M | |||
| Depreciation Amortization | 12.73M | 16.07M | 15.93M | 13.19M | 19.61M | |||
| Change In Working Capital | -17.79M | -20.45M | -14.73M | -1.54M | -4.91M | |||
| Interest Paid | 3.84M | 5.60M | 4.05M | 3.95M | 4.45M | |||
| Taxes Paid | 15.54M | 15.58M | 655.00K | 1.24M | 0.00 | |||
| Other non cash items | 14.80M | 11.08M | -6.48M | -4.18M | 62.00K | |||
| OPERATING CASH FLOW | 6.08M | -1.79M | -17.30M | 22.46M | 37.84M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.00M | -796.00K | -1.46M | -1.98M | -16.72M | |||
| Other Investing Activity | 41.65M | 32.41M | -127.92M | 7.30M | -4.59M | |||
| INVESTING CASH FLOW | 40.65M | 31.62M | -129.39M | 5.32M | -21.30M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -33.78M | -34.39M | -5.13M | -3.31M | -3.22M | |||
| Stock Issued/Repurchased | 4.94M | 5.58M | 8.13M | 2.28M | 4.72M | |||
| Other Financing Activity | -9.81M | -5.60M | -4.05M | -3.95M | -29.45M | |||
| FINANCING CASH FLOW | -38.66M | -34.41M | -1.04M | -4.98M | -27.95M | |||
| Exchange Rate Effect | 132.00K | -2.21M | 2.13M | -7.38M | -1.82M | |||
| CHANGE IN CASH | 8.20M | -6.80M | -145.60M | 15.42M | -13.23M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 6.08M | -1.79M | -17.30M | 22.46M | 37.84M | |||
| Capital Expenditure | -1.00M | -796.00K | -1.46M | -1.98M | -16.72M | |||
| FREE CASH FLOW | 5.08M | -2.59M | -18.77M | 20.48M | 21.13M | |||
All data in USD